Dermatomyositis: all 175 studies
Page 1 of 2. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- A Study of BMS-986553 in Participants With Refractory Autoimmune DiseasesNot yet recruitingNCT07873931Phase 1
- FT839 in Autoimmune DiseasesRecruitingNCT07800871Phase 1/2
- Pain-Sleep in Rheumatic DiseaseNot yet recruitingNCT07775612Not applicable
- BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune DiseaseNot yet recruitingNCT07729995Phase 1
- BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory MyopathyRecruitingNCT07715136Phase 1
- Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune DiseasesRecruitingNCT07558850Not applicable
- Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) StudyRecruitingNCT07486869Phase 2
- A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101RecruitingNCT07403188
- RCT of Tocilizumab for Anti-MDA5+DMRecruitingNCT07377058Not applicable
- MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)RecruitingNCT07374107
- Hypnotherapy for Needle-related Procedural Pain and Anxiety Management in a Pediatric SettingNot yet recruitingNCT07349667Not applicable
- Panniculitis in DermatomyositisRecruitingNCT07345949
- Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLESRecruitingNCT07265999
- Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic DiseasesRecruitingNCT07184450Phase 1
- Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)RecruitingNCT07160205Phase 2/3
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or DermatomyositisNot yet recruitingNCT07122648Phase 2
- A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesRecruitingNCT07115745Phase 1
- FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)RecruitingNCT07111065Phase 2
- Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune DisordersRecruitingNCT07089121Phase 1/2
- A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseRecruitingNCT07085104Phase 1
- Photoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treatment Response EvaluationRecruitingNCT07037472Not applicable
- Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis StressNot yet recruitingNCT06999109Not applicable
- Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy TrialRecruitingNCT06919380Phase 1
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.RecruitingNCT06916806Phase 1
- Mesenchymal Stem Cells Infusion in Patients With Autoimmune DiseasesEnrolling by invitationNCT06888973Phase 1/2
- Study of NM8074 in Patients with Dermatomyositis (DM)Not yet recruitingNCT06887738Phase 2
- Topical Ruxolitinib Cream for Refractory Cutaneous DermatomyositisRecruitingNCT06857240Phase 2
- Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic DiseasesRecruitingNCT06732674Not applicable
- Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)Enrolling by invitationNCT06723106Phase 1
- A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory MyopathiesRecruitingNCT06698796Phase 3
- Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)RecruitingNCT06686524Phase 1
- Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune DiseasesRecruitingNCT06685042Phase 1/2
- Intralesional Injection of STS in Treatment of CalcinosisRecruitingNCT06672822Phase 2
- Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin DiseasesRecruitingNCT06599411
- Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile DermatomyositisRecruitingNCT06569472Phase 1
- Evaluation of Patients With Refractory Dermatomyositis Using [18F] FAPI-74 PET/MRI ImagingNot yet recruitingNCT06568783Phase 2
- Neutrophil Extracellular Traps in Different Forms of Systemic SclerosisRecruitingNCT06462768
- A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)RecruitingNCT06455449Phase 3
- 3T Therapy in the Treatment of MDA5-positive DermatomyositisEnrolling by invitationNCT06438679Phase 4
- Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological DiseasesRecruitingNCT06387654
- Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)RecruitingNCT06371417Phase 1
- CAR-T Cells in Systemic B Cell Mediated Autoimmune DiseaseRecruitingNCT06347718Phase 1/2
- Rheumatology Diet StudyRecruitingNCT06339957
- Study of KYV-101 Anti-CD19 CAR T Therapy in Adult DermatomyositisRecruitingNCT06298019Phase 1
- Microecology and Immunity in Patients With Anti-MDA5 Antibody Positive Dermatomyositis and Interstitial Lung DiseaseRecruitingNCT06203249
- RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory MyopathyRecruitingNCT06154252Phase 2/3
- Study on Lymphocyte Subsets of Peripheral Blood in Patients With Nonmyopathic Dermatomyositis Complicated With Pulmonary Interstitial DiseaseRecruitingNCT06149039
- Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune DiseaseRecruitingNCT06056921Phase 1
- Evaluation of Severity in Juvenile and Adult-onset DermatomyositisRecruitingNCT06004817
- Safety and Preliminary Clinical Activity of Itolizumab in DermatomyositisNot yet recruitingNCT05986162Phase 1
- A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory MyopathyEnrolling by invitationNCT05979441Phase 3
- A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]RecruitingNCT05895786Phase 3
- Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory MyopathyRecruitingNCT05833711Phase 2
- Natural History of Inflammatory Muscle DiseasesRecruitingNCT05738824
- Baricitinib in Patients With Relapsing or naïve DermatomyositisRecruitingNCT04972760Phase 3
- Rheumatology Patient Registry and BiorepositoryRecruitingNCT04402086
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 1
- Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot StudyRecruitingNCT03582800Phase 2
- Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)RecruitingNCT02945345
- Environmental Risk Factors for the Anti-synthetase SyndromeRecruitingNCT01276470
- Adult and Juvenile MyositisRecruitingNCT00017914
- Study of M5049 in DM and PM Participants (NEPTUNIA)TerminatedNCT05650567Phase 2Results posted
- An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent StudyCompletedNCT05192200Phase 2Results posted
- COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
- Ravulizumab Versus Placebo in Adult Participants With DermatomyositisTerminatedNCT04999020Phase 2/3Results posted
- Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.CompletedNCT04628936Phase 2Results posted
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)TerminatedNCT04044690Phase 3Results posted
- A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or DermatomyositisCompletedNCT04033926Phase 2Results posted
- A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care TreatmentsTerminatedNCT03981744Phase 3Results posted
- Study Evaluating Efficacy and Safety of Octanorm in Patients With DermatomyositisTerminatedNCT03686969Phase 3Results posted
- Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant DermatomyositisCompletedNCT03529955Phase 2Results posted
- Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult DermatomyositisCompletedNCT03267277Phase 2/3Results posted
- A Study In Adults With Moderate To Severe DermatomyositisCompletedNCT03181893Phase 2Results posted
- Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory MyopathyCompletedNCT02971683Phase 3Results posted
- Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)CompletedNCT02728752Phase 3Results posted
- Trial of IMO-8400 in Adult Patients With DermatomyositisCompletedNCT02612857Phase 2Results posted
- Abatacept in Juvenile DermatomyositisCompletedNCT02594735Phase 4Results posted
- Safety, Tolerability, and Efficacy of JBT-101 in Subjects With DermatomyositisTerminatedNCT02466243Phase 2Results posted
- Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of DermatomyositisCompletedNCT02245841Phase 4Results posted
- Tocilizumab in the Treatment of Refractory Polymyositis and DermatomyositisCompletedNCT02043548Phase 2Results posted
- Safety and Efficacy of BAF312 in DermatomyositisTerminatedNCT02029274Phase 2Results posted
- Acthar in Treatment of Refractory Dermatomyositis and PolymyositisCompletedNCT01906372Phase 2Results posted
- Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated CalcinosisCompletedNCT01572844Phase 2Results posted
- Efficacy and Tolerability of BAF312 in Patients With Polymyositis and DermatomyositisTerminatedNCT01148810Phase 2Results posted
- A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With DermatomyositisTerminatedNCT01140503Not applicableResults posted
- Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DMCompletedNCT00651040Phase 3Results posted
- Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant TacrolimusCompletedNCT00504348Phase 2/3Results posted
- Five-year Actively Controlled Clinical Trial in New Onset Juvenile DermatomyositisCompletedNCT00323960Phase 3Results posted
- A Pilot Study of Etanercept in DermatomyositisCompletedNCT00112385Phase 1Results posted
- Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)CompletedNCT00106184Phase 2Results posted
- Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical ParametersActive, not recruitingNCT07531446
- Comparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children and Adolescents With Rheumatic DiseasesCompletedNCT07138157Not applicable
- Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile DermatomyositisWithdrawnNCT07012057Phase 2
- Interest of LC-OCT for Diagnosing Inflammatory Dermatoses: ODIN (OCT Dermotoses INflammatoires)CompletedNCT06874712
- Biomarkers of Cancer-Associated MyositisActive, not recruitingNCT06808672
- Phase 2 Study of Rapcabtagene Autoleucel in MyositisActive, not recruitingNCT06665256Phase 2
- Fitness Integrative Training for Pediatric Rheumatology DisordersCompletedNCT06556992Not applicable
- A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant DermatomyositisCompletedNCT06433999Phase 2
- A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With DermatomyositisActive, not recruitingNCT06284954Phase 2